{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:41Z","timestamp":1787010101176,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>\n                    This study was performed to evaluate the relationship between the CHA\n                    <jats:sub>2<\/jats:sub>\n                    DS\n                    <jats:sub>2<\/jats:sub>\n                    -VASc score and no-reflow (NR) phenomena in patients with non-ST-segment elevation myocardial infarction (NSTEMI). A total number of 428 consecutive patients with NSTEMI were assessed for this study. Patients were divided into 2 groups, those with NR, NR(+) (n=84), and those without NR, NR(-) (n=307), according to their post-PCI, no-reflow status. The CHA\n                    <jats:sub>2<\/jats:sub>\n                    DS\n                    <jats:sub>2<\/jats:sub>\n                    -VASc score was significantly higher in the NR(+) group compared to the NR(-) (3.48 \u00b1 1.19 vs 1.81 \u00b1 0.82,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). After a multivariate regression analysis, a higher CHA\n                    <jats:sub>2<\/jats:sub>\n                    DS\n                    <jats:sub>2<\/jats:sub>\n                    -VASc score (OR: 6.52, 95% CI: 3.51\u201312.14,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001), hs-Troponin (OR: 1.077, 95% CI: 1.056\u20131.099,\n                    <jats:italic toggle=\"yes\">P&lt;<\/jats:italic>\n                    0.001) and TTG (OR: 1.563, 95% CI: 1.134\u20132.154,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.006) were independent predictors of NR. CHA\n                    <jats:sub>2<\/jats:sub>\n                    DS\n                    <jats:sub>2<\/jats:sub>\n                    -VASc score is associated with higher risk of no-reflow in patients with NSTEMI undergoing PCI.\n                  <\/jats:p>","DOI":"10.1097\/mca.0000000000000781","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:41:36Z","timestamp":1568425296000},"page":"7-12","source":"Crossref","is-referenced-by-count":30,"title":["The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction"],"prefix":"10.1097","volume":"31","author":[{"given":"Hasan Ali","family":"Barman","sequence":"first","affiliation":[{"name":"Cardiology Department, Okmeydani Training and Research Hospital, Okmeydani, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Kahyaoglu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Nevsehir State Hospital, Nevsehir"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eser","family":"Durmaz","sequence":"additional","affiliation":[{"name":"Cardiology Department, Istanbul University Cerrahpasa School of Medicine, Fatih"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Atici","sequence":"additional","affiliation":[{"name":"Cardiology Department, \u0130stanbul Gaziosmanpasa Taksim Training and Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Gulsen","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Tugrul","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Burak","family":"Isleyen","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Rifat","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Gungor","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Siyami Ersek Cardiothoracic Surgery Center, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertugrul","family":"Okuyan","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Sahin","sequence":"additional","affiliation":[{"name":"Cardiology Department, Bagcilar Training ve Research Hospital, Bagcilar Center, Bagcilar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIRCULATIONAHA.115.018931","article-title":"Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009.","volume":"133","author":"Hartley","year":"2016","journal-title":"Circulation"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/heart.89.9.983","article-title":"Pathology of coronary microembolisation and no reflow.","volume":"89","author":"Falk","year":"2003","journal-title":"Heart"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.CIR.85.5.1699","article-title":"Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.","volume":"85","author":"Ito","year":"1992","journal-title":"Circulation"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical implications of the \u2018no reflow\u2019 phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"R6-20230924","doi-asserted-by":"crossref","first-page":"8G","DOI":"10.1016\/S0002-9149(98)00046-0","article-title":"Assessing the relation between coronary reflow and myocardial reflow.","volume":"81","author":"Ito","year":"1998","journal-title":"Am J Cardiol"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","article-title":"Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.","volume":"117","author":"Jaffe","year":"2008","journal-title":"Circulation"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon.","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation.","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"e111167","DOI":"10.1371\/journal.pone.0111167","article-title":"Use of CHADS2 and CHA2DS2-vasc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry.","volume":"9","author":"Chua","year":"2014","journal-title":"Plos One"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.atherosclerosis.2014.08.026","article-title":"The CHADS2 and CHA2DS2-vasc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.","volume":"237","author":"Chan","year":"2014","journal-title":"Atherosclerosis"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow.","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.103.21.2550","article-title":"Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.","volume":"103","author":"Gibson","year":"2001","journal-title":"Circulation"},{"key":"R19-20230924","first-page":"932","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial.","volume":"31","year":"1985","journal-title":"N Engl J Med"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/hrt.2005.075077","article-title":"Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.","volume":"92","author":"Vijayalakshmi","year":"2006","journal-title":"Heart"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":"Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.","volume":"36","author":"Morishima","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","article-title":"Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.","volume":"111","author":"Harrison","year":"2013","journal-title":"Am J Cardiol"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R25-20230924","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2014.02.530","article-title":"A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).","volume":"63","author":"Carrick","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R26-20230924","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00380-011-0144-2","article-title":"Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention.","volume":"27","author":"Chen","year":"2012","journal-title":"Heart Vessels"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ccd.21715","article-title":"Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.","volume":"72","author":"Rezkalla","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R28-20230924","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(02)02626-8","article-title":"Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.","volume":"41","author":"Iwakura","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R29-20230924","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3132\/dvdr.2005.021","article-title":"The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes.","volume":"2","author":"Collet","year":"2005","journal-title":"Diab Vasc Dis Res"},{"key":"R30-20230924","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R31-20230924","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrcardio.2015.72","article-title":"Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.","volume":"12","author":"Dean","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R32-20230924","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update.","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"R33-20230924","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"R34-20230924","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCA.0000000000000388","article-title":"Importance and usage of the CHA2DS2-vasc score in predicting acute stent thrombosis.","volume":"27","author":"\u00dcnal","year":"2016","journal-title":"Coron Artery Dis"},{"key":"R35-20230924","first-page":"742","article-title":"CHA2DS2-vasc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.","volume":"16","author":"Ta\u015folar","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"R36-20230924","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0003319715622844","article-title":"CHA2DS2-vasc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention.","volume":"67","author":"Ipek","year":"2016","journal-title":"Angiology"},{"key":"R37-20230924","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1076029616646874","article-title":"CHA2DS2-vasc score predicts in-hospital and long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention.","volume":"23","author":"Bozbay","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"R38-20230924","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15171\/jcvtr.2018.08","article-title":"CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention.","volume":"10","author":"Mirbolouk","year":"2018","journal-title":"J Cardiovasc Thorac Res"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T03:07:39Z","timestamp":1695524859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000781","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}